reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating elderly patients with aplastic anemia for anemia, aplastic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Jan 2025: Trial registered, NCT06769568

The trials

NCT06769568: Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic Anemia

State
Not started
Phase
Phase 2
People
20 planned
Started
31 Jan 2025
Primary completion
30 Sep 2028
Arms
reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating
Results
None posted
  1. 10 Jan 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.